SG3 Management’s LeonaBio Inc LONA Stock Holding History

SG3 Management’s Portfolio LONA Stock Details LONA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,300	Closed	-$211K	–	432
2022 Q1	$311K	Sell	2,300 -2,200	-49%	-$232K	0.01%	688
2021 Q4	$586K	Buy	+4,500	New	+$569K	0.01%	600

Other funds holding LONA

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PFO

Pathstone Family Office Englewood, New Jersey $13.1B AUM 20.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

Bristlecone Advisors Bellevue, Washington $1.2B AUM 19.79% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SG3 Management's LONA Position: Q2 2022 in Review

SG3 Management sold out of LeonaBio Inc (LONA) in Q2 2022, closing a stake of 2,300 shares — an estimated $211K sold.

SG3 Management first reported a position in LONA in Q4 2021 and held it in 2 quarters. The position peaked at $586K in Q4 2021. 98 funds tracked by Wall St. Rank hold LONA as of Q2 2022.

SG3 Management reported no remaining LeonaBio Inc position as of Q2 2022 after selling out during the quarter.
SG3 Management sold 2,300 LeonaBio Inc shares in Q2 2022, an estimated $211K.
SG3 Management first reported a position in LeonaBio Inc in Q4 2021 and held it in 2 quarters.
SG3 Management's LeonaBio Inc position peaked at $586K in Q4 2021.
98 funds tracked by Wall St. Rank held LeonaBio Inc as of Q2 2022.

Based on SG3 Management's 13F filing for Q2 2022, filed 15 Aug 2022.